HSBC initiated coverage on shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) in a research report report published on Monday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $13.00 target price on the stock. A number of other analysts have also weighed in on the stock. Bank of America upped their […]
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 […]
UBS Group upgraded shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) from a neutral rating to a buy rating in a report released on Monday, MarketBeat.com reports. UBS Group currently has $13.00 price objective on the stock, up from their prior price objective of $11.00. A number of other brokerages have also commented on […]
Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) have earned an average rating of “Hold” from the seven ratings firms that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and three have assigned a buy recommendation to […]
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has been assigned an average rating of “Hold” from the seven analysts that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and three have given a buy recommendation to the […]